Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 83%
In fiscal 2025, PROTHENA CORPORATION PUBLIC LIMITED COMPANY reported revenue of $10M, down 92.8% year over year. Operating margin was -2216.4% and net margin -2520.6%, on a free-cash-flow margin of n/a with capital expenditure at n/a of revenue. Every figure is computed directly from PRTA's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $10M | -2216.4% | -2520.6% |
| FY2024 | $135M | -114.4% | -90.5% |
| FY2023 | $91M | -209.1% | -160.9% |
| FY2022 | $54M | -244.1% | -217.0% |
| FY2021 | $201M | 35.9% | 33.4% |
How does PRTA compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.